Microcarriers Market Size and Forecasts (2020 – 2030)

Microcarriers Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Product (Media and Reagents, and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPBT00002183 Category: Tags: , ,

$3,185$5,985

Description

According to our latest study on “Microcarriers Market Forecast to 2030 – Global Analysis –Product, Equipment, Application, and End User,” the market is expected to reach US$ 4.178 billion in 2030 from US$ 1.625 billion in 2022. The report highlights the key factors driving the market and prominent players with their developments. Key factors driving the market growth are need for cell therapies with rising incidence of cancer and infectious diseases, and increasing popularity of outsourcing cell and gene therapy manufacturing boost the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned below:

• In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US.

• In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier’s proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan.

• In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments.

• In January 2022, FUJIFILM Corporation announced its plan to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility is readily expandable and flexible to produce clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies.

• In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category.

Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Based on product, the microcarriers market is divided into microcarrier beads and media & reagents. In 2022, the microcarrier beads segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022–2030. Growing cell biology research, demand for regenerative medicines and biopharmaceuticals, and the presence of multiple manufacturers and suppliers contribute to the considerable market growth. Extensive product offerings and continuous developments in microcarrier technology offer lucrative opportunities for the growth of key market players. Major companies such as Sartorius AG offer microcarrier beads that are free of animal components and proteins coated.

Based on equipment, the microcarriers market is segmented into bioreactors, culture vessels, and others. In 2022, the bioreactors segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022–2030. Bioreactors are manufacturing devices or vessels in which biological reactions are carried out; they are used to grow microorganisms such as yeast, bacteria, or animal cells in an appropriate environment under controlled conditions. They maintain a supportable environment for cell growth and product formation. A microcarrier-based bioreactor allows real-time off-line monitoring of cell growth and quality and metabolite analyses, which can be utilised to detect errors and rectify them immediately.

Based on application, the microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. In 2022, the biopharmaceutical production segment held the largest market share, and same is estimated to register the fastest CAGR of 13.1% during 2022–2030. Biopharmaceutical production segment is further subsegmented into therapeutic production and vaccine production. Microcarriers are an established technology in the biopharmaceutical industry, which, in combination with stirred-tank bioreactors, can provide the necessary environment for large-scale production of adherent cells. Biodegradable materials used in the production of microcarriers have the capability to solve in vitro disease modeling. Microcarriers find applications in biopharmaceutical industries as they expand the spectrum of controllable biodegradation.

Based on end user, the microcarriers market is segmented pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations (CMOs), and academic and research institutes. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. Moreover, the same is estimated to register the highest CAGR of 12.9% in the market during the forecast period. Pharmaceutical companies hold a major share of the total medicine production. Pharmaceutical manufacturing processes are often based on biotechnology principles that involve the use of bacteria to produce insulin, human growth hormone, etc., products. The pharmaceutical and biotechnological industries have witnessed extensive growth in the past decade mainly owing to increased R&D activities and regulatory approvals for the introduction of new microbe-based products. Such a massive scale of innovation is projected to drive the adoption of bioreactors in pharmaceutical and biotechnological manufacturing in the coming years, eventually favoring the microcarriers market growth for the pharmaceutical and biotechnological segment.

United States Food and Drug Administration (USFDA), Institute for Clinical and Economic Review (ICER), Centers for Disease Control and Prevention (CDC), are a few key primary and secondary sources referred to while preparing the report on the microcarriers market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Breast Cancer Segment by Application to Account Larger Share in Microcarriers Market during 2022–2030

According to our latest study on “Microcarriers Market Forecast to 2030 – Global Analysis –Product, Equipment, Application, and End User,” the market is expected to reach US$ 4.178 billion in 2030 from US$ 1.625 billion in 2022. The report highlights trends prevailing in the market, and factors driving and hindering the microcarriers market growth.

The microcarriers market growth is due to the need for cell therapies with rising incidence of cancer and infectious diseases, and the increasing popularity of outsourcing cell and gene therapy manufacturing boosts the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.

The microcarriers market, by application, is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering, regenerative medicine, and others. In 2022, the biopharmaceutical production segment held the largest market share, and same is estimated to register the fastest CAGR of 13.1% during 2022–2030. Biopharmaceutical production segment is further subsegmented into therapeutic production and vaccine production. Microcarriers are an established technology in the biopharmaceutical industry, which, in combination with stirred-tank bioreactors, can provide the necessary environment for large-scale production of adherent cells. Biodegradable materials used in the production of microcarriers have the capability to solve in vitro disease modeling. Microcarriers find applications in biopharmaceutical industries as they expand the spectrum of controllable biodegradation.

Asia Pacific is the fastest-growing region of the global newborn screening market in 2022. The growth of the market in this region can be associated with the growing emphasis of businesses on cost optimization, burgeoning efforts to streamline clinical processes, supportive government policies, and increasing number of clinical trials. The 13th Chinese plan expected a more than 4% contribution of the biotechnology industry to the GDP in 2020, which would be nearly 10–20 life-science parities. More than 100 life-science parks controlled by local governments are functional across China, and these centers entice enterprises with tax advantages and subsidies. State, provincial, and local governments are reported to have already invested more than US$ 100 billion in the biosciences sector to meet the goals of the five-year plan of China. According to a study published in Nature in 2021, China is home to more than 50% of all cell therapy trials across the world. The country currently has nearly 400 ongoing CAR-T trials centered on hematology, and oncology and solid tumors. In 2021, the National Medical Products Administration (NMPA) approved Fosun Kite’s Yescarta and JW Therapeutics’ Relma-cel, with which cell therapies in China entered a new era.

Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, Polysciences Inc are among the leading companies operating in the vital signs monitoring devices market.

Companies operating in the microcarriers market adopt various organic and inorganic strategies. Growth strategies mainly include product launches and product approvals, mergers & acquisitions, collaborations, and partnerships are among the growth strategies witnessed in the microcarriers market.

A few of the significant developments by key market players are listed below.

• In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US..

• In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier’s proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan.

• In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments.

• In January 2022, FUJIFILM Corporation announced its plan to acquire from Atara Biotherapeutics, Inc’s cell therapy manufacturing facility. The facility is readily expandable and flexible to produce clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Microcarriers Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Microcarriers Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.2 Market Restraints
5.2.1 High Cost of Biologics and Cell-based Therapies
5.3 Market Opportunities
5.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
5.4 Future Trends
5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
5.5 Impact Analysis
6. Microcarriers Market – Global Market Analysis
6.1 Microcarriers Market Revenue (US$ Mn), 2022 – 2030
7. Microcarriers Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Microcarrier Beads
7.3.1 Overview
7.3.2 Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Media and Reagents
7.4.1 Overview
7.4.2 Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8. Microcarriers Market – Revenue and Forecast to 2030 – by Equipment
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Bioreactors
8.3.1 Overview
8.3.2 Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Culture Vessels
8.4.1 Overview
8.4.2 Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9. Microcarriers Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
9.3 Biopharmaceutical Production
9.3.1 Overview
9.3.2 Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cell and Gene Therapy
9.4.1 Overview
9.4.2 Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Tissue Engineering and Regenerative Medicine
9.5.1 Overview
9.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
10. Microcarriers Market Revenue and Forecasts To 2030 – End User
10.1 Overview
10.2 Global Microcarriers Market Share by End User – 2022 & 2030 (%)
10.3 Pharmaceutical and Biotechnology Companies
10.3.1 Overview
10.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market– Revenue and Forecast to 2030 (US$ Million)
10.4 Contract Research Organizations and Contract Manufacturing Organizations
10.4.1 Overview
10.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market– Revenue and Forecast to 2028 (US$ Million)
10.5 Academic and Research Institutes
10.5.1 Overview
10.5.2 Academic and Research Institutes: Microcarriers Market– Revenue and Forecast to 2028 (US$ Million)
11. Microcarriers Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America Microcarriers Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America: Microcarriers Market, by Product
11.1.4 North America: Microcarriers Market, by Equipment
11.1.5 North America: Microcarriers Market, by Application
11.1.5.1 North America: Microcarriers Market, by Biopharmaceutical Production
11.1.6 North America: Microcarriers Market, by End User
11.1.7 North America: Microcarriers Market, by Country
11.1.7.1 US
11.1.7.1.1 Overview
11.1.7.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.1.3 US: Microcarriers Market, by Product
11.1.7.1.4 US: Microcarriers Market, by Equipment
11.1.7.1.5 US: Microcarriers Market, by Application
11.1.7.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
11.1.7.1.6 US: Microcarriers Market, by End User
11.1.7.2 Canada
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.2.3 Canada: Microcarriers Market, by Product
11.1.7.2.4 Canada: Microcarriers Market, by Equipment
11.1.7.2.5 Canada: Microcarriers Market, by Application
11.1.7.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
11.1.7.2.6 Canada: Microcarriers Market, by End User
11.1.7.3 Mexico
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.1.7.3.3 Mexico: Microcarriers Market, by Product
11.1.7.3.4 Mexico: Microcarriers Market, by Equipment
11.1.7.3.5 Mexico: Microcarriers Market, by Application
11.1.7.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
11.1.7.3.6 Mexico: Microcarriers Market, by End User
11.2 Europe Microcarriers Market, Revenue and Forecast To 2030
11.2.1 Overview
11.2.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe: Microcarriers Market, by Product
11.2.4 Europe: Microcarriers Market, by Equipment
11.2.5 Europe: Microcarriers Market, by Application
11.2.5.1 Europe: Microcarriers Market, by Biopharmaceutical Production
11.2.6 Europe: Microcarriers Market, by End User
11.2.7 Europe: Microcarriers Market, by Country
11.2.7.1 Germany
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
11.2.7.1.3 Germany: Microcarriers Market, by Product
11.2.7.1.4 Germany: Microcarriers Market, by Equipment
11.2.7.1.5 Germany: Microcarriers Market, by Application
11.2.7.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
11.2.7.1.6 Germany: Microcarriers Market, by End User
11.2.7.2 UK
11.2.7.2.1 Overview
11.2.7.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.2.3 UK: Microcarriers Market, by Product
11.2.7.2.4 UK: Microcarriers Market, by Equipment
11.2.7.2.5 UK: Microcarriers Market, by Application
11.2.7.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
11.2.7.2.6 UK: Microcarriers Market, by End User
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.3.3 France: Microcarriers Market, by Product
11.2.7.3.4 France: Microcarriers Market, by Equipment
11.2.7.3.5 France: Microcarriers Market, by Application
11.2.7.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
11.2.7.3.6 France: Microcarriers Market, by End User
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
11.2.7.4.3 Italy: Microcarriers Market, by Product
11.2.7.4.4 Italy: Microcarriers Market, by Equipment
11.2.7.4.5 Italy: Microcarriers Market, by Application
11.2.7.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
11.2.7.4.6 Italy: Microcarriers Market, by End User
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.5.3 Spain: Microcarriers Market, by Product
11.2.7.5.4 Spain: Microcarriers Market, by Equipment
11.2.7.5.5 Spain: Microcarriers Market, by Application
11.2.7.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
11.2.7.5.6 Spain: Microcarriers Market, by End User
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.2.7.6.3 Rest of Europe: Microcarriers Market, by Product
11.2.7.6.4 Rest of Europe: Microcarriers Market, by Equipment
11.2.7.6.5 Rest of Europe: Microcarriers Market, by Application
11.2.7.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
11.2.7.6.6 Rest of Europe: Microcarriers Market, by End User
11.3 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
11.3.1 Overview
11.3.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific: Microcarriers Market, by Product
11.3.4 Asia Pacific: Microcarriers Market, by Equipment
11.3.5 Asia Pacific: Microcarriers Market, by Application
11.3.5.1 Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
11.3.6 Asia Pacific: Microcarriers Market, by End User
11.3.7 Asia Pacific: Microcarriers Market, by Country
11.3.7.1 China
11.3.7.1.1 Overview
11.3.7.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
11.3.7.1.3 China: Microcarriers Market, by Product
11.3.7.1.4 China: Microcarriers Market, by Equipment
11.3.7.1.5 China: Microcarriers Market, by Application
11.3.7.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
11.3.7.1.6 China: Microcarriers Market, by End User
11.3.7.2 Japan
11.3.7.2.1 Overview
11.3.7.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.2.3 Japan: Microcarriers Market, by Product
11.3.7.2.4 Japan: Microcarriers Market, by Equipment
11.3.7.2.5 Japan: Microcarriers Market, by Application
11.3.7.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
11.3.7.2.6 Japan: Microcarriers Market, by End User
11.3.7.3 India
11.3.7.3.1 Overview
11.3.7.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.3.3 India: Microcarriers Market, by Product
11.3.7.3.4 India: Microcarriers Market, by Equipment
11.3.7.3.5 India: Microcarriers Market, by Application
11.3.7.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
11.3.7.3.6 India: Microcarriers Market, by End User
11.3.7.4 Australia
11.3.7.4.1 Overview
11.3.7.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
11.3.7.4.3 Australia: Microcarriers Market, by Product
11.3.7.4.4 Australia: Microcarriers Market, by Equipment
11.3.7.4.5 Australia: Microcarriers Market, by Application
11.3.7.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
11.3.7.4.6 Australia: Microcarriers Market, by End User
11.3.7.5 South Korea
11.3.7.5.1 Overview
11.3.7.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.5.3 South Korea: Microcarriers Market, by Product
11.3.7.5.4 South Korea: Microcarriers Market, by Equipment
11.3.7.5.5 South Korea: Microcarriers Market, by Application
11.3.7.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
11.3.7.5.6 South Korea: Microcarriers Market, by End User
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.3.7.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
11.3.7.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
11.3.7.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
11.3.7.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
11.3.7.6.6 Rest of Asia Pacific: Microcarriers Market, by End User
11.4 Middle East & Africa Microcarriers Market, Revenue and Forecast To 2030
11.4.1 Overview
11.4.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa: Microcarriers Market, by Product
11.4.4 Middle East & Africa: Microcarriers Market, by Equipment
11.4.5 Middle East & Africa: Microcarriers Market, by Application
11.4.5.1 Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.6 Middle East & Africa: Microcarriers Market, by End User
11.4.7 Middle East & Africa: Microcarriers Market, by Country
11.4.7.1 Saudi Arabia
11.4.7.1.1 Overview
11.4.7.1.2 Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
11.4.7.1.3 Saudi Arabia: Microcarriers Market, by Product
11.4.7.1.4 Saudi Arabia: Microcarriers Market, by Equipment
11.4.7.1.5 Saudi Arabia: Microcarriers Market, by Application
11.4.7.1.5.1 Saudi Arabia: Microcarriers Market, by Biopharmaceutical Production
11.4.7.1.6 Saudi Arabia: Microcarriers Market, by End User
11.4.7.2 South Africa
11.4.7.2.1 Overview
11.4.7.2.2 South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.2.3 South Africa: Microcarriers Market, by Product
11.4.7.2.4 South Africa: Microcarriers Market, by Equipment
11.4.7.2.5 South Africa: Microcarriers Market, by Application
11.4.7.2.5.1 South Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.7.2.6 South Africa: Microcarriers Market, by End User
11.4.7.3 UAE
11.4.7.3.1 Overview
11.4.7.3.2 UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.4.7.3.3 UAE: Microcarriers Market, by Product
11.4.7.3.4 UAE: Microcarriers Market, by Equipment
11.4.7.3.5 UAE: Microcarriers Market, by Application
11.4.7.3.5.1 UAE: Microcarriers Market, by Biopharmaceutical Production
11.4.7.3.6 UAE: Microcarriers Market, by End User
11.4.7.4 Rest Middle East & Africa
11.4.7.4.1 Overview
11.4.7.4.2 Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
11.4.7.4.3 Rest Middle East & Africa: Microcarriers Market, by Product
11.4.7.4.4 Rest Middle East & Africa: Microcarriers Market, by Equipment
11.4.7.4.5 Rest Middle East & Africa: Microcarriers Market, by Application
11.4.7.4.5.1 Rest Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
11.4.7.4.6 Rest Middle East & Africa: Microcarriers Market, by End User
11.5 South & Central America Microcarriers Market, Revenue and Forecast To 2030
11.5.1 Overview
11.5.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America: Microcarriers Market, by Product
11.5.4 South & Central America: Microcarriers Market, by Equipment
11.5.5 South & Central America: Microcarriers Market, by Application
11.5.5.1 South & Central America: Microcarriers Market, by Biopharmaceutical Production
11.5.6 South & Central America: Microcarriers Market, by End User
11.5.7 South & Central America: Microcarriers Market, by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
11.5.7.1.3 Brazil: Microcarriers Market, by Product
11.5.7.1.4 Brazil: Microcarriers Market, by Equipment
11.5.7.1.5 Brazil: Microcarriers Market, by Application
11.5.7.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
11.5.7.1.6 Brazil: Microcarriers Market, by End User
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.2.3 Argentina: Microcarriers Market, by Product
11.5.7.2.4 Argentina: Microcarriers Market, by Equipment
11.5.7.2.5 Argentina: Microcarriers Market, by Application
11.5.7.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
11.5.7.2.6 Argentina: Microcarriers Market, by End User
11.5.7.3 Rest Of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
11.5.7.3.3 Rest Of South & Central America: Microcarriers Market, by Product
11.5.7.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
11.5.7.3.5 Rest Of South & Central America: Microcarriers Market, by Application
11.5.7.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
11.5.7.3.6 Rest Of South & Central America: Microcarriers Market, by End User
12. Microcarriers Market–Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 Teijin Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bio-Rad Laboratories Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 denovoMATRIX GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sartorius AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Danaher Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Corning Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eppendorf SE
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Percell Biolytica AB
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Asahi Kasei Corp
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Polysciences Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Microcarriers Market Segmentation
Table 2. North America Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 3. North America Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 4. North America Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 5. North America Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 6. North America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 7. US Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 8. US Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 9. US Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 10. US Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 11. US: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 12. Canada Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 13. Canada Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 14. Canada Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 15. Canada Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 16. Canada: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Mexico Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 18. Mexico Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 19. Mexico Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 20. Mexico Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 21. Mexico: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 22. Europe Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 23. Europe Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 24. Europe Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 25. Europe Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 26. Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 27. Germany Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 28. Germany Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 29. Germany Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 30. Germany Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 31. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 32. UK Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 33. UK Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 34. UK Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 35. UK Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 36. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 37. France Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 38. France Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 39. France Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 40. France Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 41. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 42. Italy Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 43. Italy Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 44. Italy Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 45. Italy Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 46. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 47. Spain Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 48. Spain Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 49. Spain Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 50. Spain Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 51. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 52. Rest of Europe Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 53. Rest of Europe Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 54. Rest of Europe Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 55. Rest of Europe Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 56. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 57. Asia Pacific Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 58. Asia Pacific Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 59. Asia Pacific Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 60. Asia Pacific Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 61. Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 62. China Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 63. China Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 64. China Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 65. China Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 66. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 67. Japan Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 68. Japan Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 69. Japan Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 70. Japan Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 71. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 72. India Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 73. India Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 74. India Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 75. India Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 76. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 77. Australia Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 78. Australia Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 79. Australia Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 80. Australia Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 81. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 82. South Korea Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 83. South Korea Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 84. South Korea Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 85. South Korea Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 86. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 87. Rest of Asia Pacific Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 88. Rest of Asia Pacific Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 89. Rest of Asia Pacific Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 90. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 91. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 92. Middle East & Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 93. Middle East & Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 94. Middle East & Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 95. Middle East & Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 96. Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 97. Saudi Arabia Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 98. Saudi Arabia Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 99. Saudi Arabia Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 100. Saudi Arabia Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 101. Saudi Arabia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 102. South Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 103. South Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 104. South Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 105. South Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 106. South Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 107. UAE Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 108. UAE Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 109. UAE Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 110. UAE Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 111. UAE: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 112. Rest Middle East & Africa Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 113. Rest Middle East & Africa Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 114. Rest Middle East & Africa Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 115. Rest Middle East & Africa Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 116. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 117. South & Central America Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 118. South & Central America Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 119. South & Central America Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 120. South & Central America Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 121. South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 122. Brazil Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 123. Brazil Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 124. Brazil Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 125. Brazil Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 126. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 127. Argentina Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 128. Argentina Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 129. Argentina Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 130. Argentina Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 131. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 132. Rest Of South & Central America Microcarriers Market, by Product – Revenue and Forecast to 2030 (USD Million)
Table 133. Rest Of South & Central America Microcarriers Market, by Equipment – Revenue and Forecast to 2030 (USD Million)
Table 134. Rest Of South & Central America Microcarriers Market, by Application – Revenue and Forecast to 2030 (USD Million)
Table 135. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production – Revenue and Forecast to 2030 (USD Million)
Table 136. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 137. Recent Organic Growth Strategies in Microcarriers Market
Table 138. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 139. Glossary of Terms

LIST OF FIGURES

Figure 1. Microcarriers Market Segmentation, By Region
Figure 2. Key Insights
Figure 3. Global – PEST Analysis
Figure 4. Microcarriers Market – Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints for Microcarriers Market
Figure 6. Microcarriers Market Revenue (US$ Mn), 2022 – 2030
Figure 7. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Microcarrier Beads: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Media and Reagents: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 11. Bioreactors: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Culture Vessels: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Biopharmaceutical Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Therapeutic Protein Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Vaccine Production: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Cell and Gene Therapy: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Tissue Engineering and Regenerative Medicine: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Microcarriers Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Global Microcarriers Market Share by End User – 2022 & 2030 (%)
Figure 22. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 23. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 24. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
Figure 25. Microcarriers Market, 2022 ($Mn)
Figure 26. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. North America: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 28. US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Microcarriers Market, 2022 ($Mn)
Figure 32. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 34. Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
Figure 35. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
Figure 38. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Microcarriers Market, 2022 ($Mn)
Figure 41. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 43. China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
Figure 44. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 45. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
Figure 47. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 48. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 49. Microcarriers Market, 2022 ($Mn)
Figure 50. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 51. Middle East & Africa: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 52. Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
Figure 53. South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
Figure 56. Microcarriers Market, 2022 ($Mn)
Figure 57. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. South & Central America: Microcarriers Market, By Countries, 2022 And 2030 (%)
Figure 59. Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
Figure 60. Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)

The List of Companies – Microcarriers Market
– Teijin Ltd
– Bio-Rad Laboratories Inc
– denovoMATRIX GmbH
– Sartorius AG
– Danaher Corp
– Corning Inc
– Eppendorf SE
– Percell Biolytica AB
– Asahi Kasei Corp
– Polysciences Inc

Reviews

There are no reviews yet.

Be the first to review “Microcarriers Market Size and Forecasts (2020 – 2030)”